• Po-Hsun Huang, Ya-Wen Lu, Yi-Lin Tsai, Yen-Wen Wu, Hung-Yuan Li, Hsin-Yun Chang, Chih-Hsing Wu, Chih-Yu Yang, Der-Cherng Tarng, Chin-Chou Huang, Li-Ting Ho, Chao-Feng Lin, Shih-Chieh Chien, Yih-Jer Wu, Hung-I Yeh, Wen-Harn Pan, Yi-Heng Li, and expert committee for the Taiwan Lipid Guidelines for Primary Prevention.
• Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
• J Formos Med Assoc. 2022 Dec 1; 121 (12): 239324072393-2407.

AbstractElevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.Copyright © 2022 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

16 keywords...

hide…